Connection

PAVEL SUMAZIN to Signal Transduction

This is a "connection" page, showing publications PAVEL SUMAZIN has written about Signal Transduction.
Connection Strength

0.173
  1. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227.
    View in: PubMed
    Score: 0.070
  2. Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood. 2010 Feb 04; 115(5):975-84.
    View in: PubMed
    Score: 0.035
  3. CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome. Exp Hematol. 2022 06; 110:34-38.
    View in: PubMed
    Score: 0.021
  4. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.019
  5. Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes. Sci Rep. 2019 04 05; 9(1):5685.
    View in: PubMed
    Score: 0.017
  6. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev. 2014 Apr 01; 28(7):765-82.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.